Abstract
The paper analyzes the incidence of acute rheumatic fever (ARF) and chronic rheumatic heart disease (CRHD) and theirs outcomes in the Tula Region in 1991 to 2011. In this period, the incidence of ARF decreased to 0.002, which was much lower than Russia's rates. That of CRHD in 2011 accounted for 1.6 per 1,000 adult population, which was comparable to the values in Russia. CRHD mortality rates showed a 2.5-fold decrease. The main causes of fatal outcomes were cardiovascular disorders.
Highlights
Представлен анализ заболеваемости острой ревматической лихорадкой (ОРЛ), хронической ревматической болезнью сердца (ХРБС), а также исходов болезни по Тульской области с 1991 по 2011 г
The paper analyzes the incidence of acute rheumatic fever (ARF) and chronic rheumatic heart disease (CRHD) and theirs outcomes in the Tula Region in 1991 to 2011
The incidence of ARF decreased to 0.002, which was much lower than Russia's rates
Summary
Заболеваемость острой ревматической лихорадкой и хронической ревматической болезнью сердца, динамика летальных исходов в Тульской области (1991–2011). Представлен анализ заболеваемости острой ревматической лихорадкой (ОРЛ), хронической ревматической болезнью сердца (ХРБС), а также исходов болезни по Тульской области с 1991 по 2011 г. The paper analyzes the incidence of acute rheumatic fever (ARF) and chronic rheumatic heart disease (CRHD) and theirs outcomes in the Tula Region in 1991 to 2011. In this period, the incidence of ARF decreased to 0.002, which was much lower than Russia's rates. Цель работы – анализ заболеваемости ОРЛ и ХРБС и летальности от последней в Тульской области в динамике за 20-летний период (1991–2011). Общая заболеваемость ОРЛ в Тульской области, по данным статистической отчетности за период с 1991 по 2011 г., представлена на рис. 1, из которого видно, что за этот период произошло существенное снижение числа случаев ОРЛ: с 730 в 1999 г. до 3 – в 2011 г
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
